Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where H. Ben Salah is active.

Publication


Featured researches published by H. Ben Salah.


Cancer Radiotherapie | 2000

Glioblastome et myxome radio-induits après traitement d’un carcinome indiffencié du nasopharynx

J. Daoud; H. Ben Salah; W Kammoun; A. Ghorbel; Mounir Frikha; R Jlidi; M Besbes; M.M Drira; M Maalej

Resume La survenue de tumeurs radio-induites est une eventualite connue depuis longtemps. Elle a surtout ete decrite apres le traitement de cancers pendant l’enfance. Les tumeurs secondaires a une irradiation d’un cancer cavum sont exceptionnelles. Des osteosarcomes craniofaciaux ont ete decrits apres traitement d’un carcinome indifferencie du nasopharynx. Nous rapportons deux observations de tumeurs radio-induites survenues respectivement trois et sept ans apres le traitement d’un carcinome indifferencie du nasopharynx. La premiere est celle d’un glioblastome temporoparietal et la deuxieme, celle d’un myxome rhino- et oropharynge. Les deux malades sont en vie apres le traitement de la seconde tumeur. Le delai d’apparition de ces tumeurs, leur situation dans le volume irradie et la dose recue a ce niveau suggerent leur nature radio-induite, mais l’etude cytogenetique serait necessaire pour confirmer l’implication de la radiotherapie dans la genese de ces cancers.


Cancer Radiotherapie | 2010

Le cancer du cavum de l’enfant et l’adulte jeune : aspects anatomocliniques, thérapeutiques et particularités évolutives

M. Frikha; N. Toumi; L. Ghorbel; H. Ben Salah; Abdelmajid Khabir; Hela Karray; R. Gargouri; Tahya Sellami Boudawara; A. Ghorbel; J. Daoud

PURPOSE We retrospectively analyzed anatomoclinic, therapeutic and evolutive particularities of 74 young patients (< or =20 years) with nasopharyngeal carcinoma treated between 1993 and 2005. PATIENTS AND METHODS Initial work-up included a fiberoptic nasofibroscopy with biopsy, tomodensitometry and/or MRI of nasopharynx and neck, chest X-ray, abdominal ultrasonography and bone scan. Patients were treated with either primary chemotherapy (epirubicin and cisplatin) followed by radiotherapy or concomitant radiochemotherapy (five fluorouracil and cisplatin). Radiotherapy was delivered to a total dose of 70 to 75 Gy to nasopharynx and involved cervical lymph nodes and 50 Gy to the remainder cervical areas. RESULTS The median age was 16 years. Sixty-three percent of patients had undifferentiated tumors. Sixty-six percent had locally advanced tumor. With a median follow-up of 107 months, one patient presented a local relapse, 24 patients developed distant metastases with a median delay of 7 months. The 5 years overall survival and disease-free survival were 66 and 65 %. Late complications were dominated by dry mouth and endocrine disorders. COMMENTS Pediatric nasopharyngeal carcinoma is characterized by an early metastatic diffusion. Local control is excellent but with severe late toxicities. New techniques of radiotherapy and new molecules of chemotherapy could improve these results.


Cancer Radiotherapie | 2014

Carcinome à petites cellules de l’ovaire

M. Bahri; R. Lahmar; H. Ben Salah; N. Kallel; M. Ben Amar; J. Daoud

Small cell carcinoma of the ovary of the hypercalcemic type is a rare tumor. We report a case in a 34-year-old patient, revealed by a pelvic pain. The imaging found a large mass of the right ovary. The patient had right oophorectomy and total hysterectomy, a left oophorectomy, pelvic and a para-aortic lymphadenectomy. She subsequently received 6 cycles of adjuvant chemotherapy followed by pelvic radiation therapy. The hypercalcemic small cell carcinoma of the ovary is a rare disease of poor prognosis. Treatment approaches include surgery, chemotherapy with the addition of radiotherapy.


Cancer Radiotherapie | 2013

Une longue survie après traitement d’un carcinome épidermoïde de la vésicule biliaire

M. Bourmèche; H. Ben Salah; M. Kallel; M.I. Beyrouti; Saloua Krichen Makni; Tahya Sellami Boudawara; M. Frikha; J. Daoud


Cancer Radiotherapie | 2011

Radiothérapie des cancers cutanés au cours du xeroderma pigmentosum

H. Ben Salah; M. Bahri; Hamida Turki; M. Abdelmoula; M. Frikha; J. Daoud


Cancer Radiotherapie | 2014

Lymphome osseux primitif localisé : à propos de quatre cas

H. Ben Salah; N. Fourati; Moez Elloumi; Tahya Sellami Boudawara; M. Frikha; J. Daoud


Cancer Radiotherapie | 2009

Intérêt de la radiothérapie dans le traitement des lymphomes gastriques agressifs localisés

H. Ben Salah; L. Ghorbel; Mohamed Krichen; Hatem Bellaaj; Moez Elloumi; M. Frikha; J. Daoud


Cancer Radiotherapie | 2018

Place de la radiothérapie pour les lymphomes du mucosa-associated lymphoid tissue gastriques : résultats d’une étude rétrospective

L. Ghorbal; A. Hdiji; H. Ben Salah; F. Elloumi; M. Frikha; Moez Elloumi; J. Daoud


Journal of Agricultural Science and Technology | 2016

Chemical Composition and Biological Activities of Zygophyllum album (L.) Essential Oil from Tunisia

Mouna Kchaou; H. Ben Salah; Kais Mnafgui; Raed Abdennabi; Néji Gharsallah; Abdelfattah Elfeki; M. Damak; Noureddine Allouche


Cancer Radiotherapie | 2016

Doses reçues par le sein après radiothérapie de maladie de Hodgkin sus-diaphragmatique chez la femme

M. Bahri; H. Ben Salah; D. Yazid; F. Kaffel; T. Sahnoun; J. Daoud

Collaboration


Dive into the H. Ben Salah's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge